Posted in Press releases, Advocacy news, Stakeholder news and views, Meeting reports, Tutorial reports, EHA's actions for Ukraine, IVDR, Health Data, member news, EU HTA Tagged personalized medicine, membership, membership renewal, Ulrich Jäger, pricing issue, EHA position on, drug pricing, EHA position on drug pricing, EHA tutorial, thalassemia, leukemia, acute leukemia, plasma cell disorders, lymphoproliferative and plasma cell disorders, precision medicine, CAR T, EBMT, Immunotherapy, Topics-in-Focus, CMML, Guidelines, HemaSphere, European Hematology Association, European LeukemiaNet, EHA, obituary, Boiron, health technology assessment, regulation, joint actions, EU Health Program, legislation, advocacy news, Stakeholder news & views’, SCD, Registry, early detection, report, EHA24, EHA congress, hemAffairs, european parliament, MEP, harmonization, CTR, funding, cancer, ATMP, IMI2, Horizon 2020, bureaucracy, BioMed, Bleeding disorders, stakeholder news & views, clinical trials, patient-centered, efficiency, IVDR, Blood Cancer, CLL, CML, lymphoma, HARMONY, T2EVOLVE, GoCART, European Cancer, ECO, Summit, anneke brand, in memoriam, TOLERATE, EU funding, Lighting the flame, hematology, specialty, career, plasma, shortage, PDMPs, HOPE, HOPE Asia, 2022, Hybrid, Bangkok, EHA-SWG Infection in Hematology, Klimko, Jean Claude Brouet, SoHO, THD, support, earthquake, Türkiye , AGM, Minutes, Members, solidarity, Morocco, Statement, i4MDS, press release, patient care, survey